- Home
- SMTI vs CHSCL Comparison
SMTI vs CHSCL Comparison
Compare SMTI & CHSCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMTI
- CHSCL
- Stock Information
- Founded
- SMTI 1982
- CHSCL N/A
- Country
- SMTI United States
- CHSCL United States
- Employees
- SMTI N/A
- CHSCL N/A
- Industry
- SMTI Medical/Dental Instruments
- CHSCL Farming/Seeds/Milling
- Sector
- SMTI Health Care
- CHSCL Industrials
- Exchange
- SMTI Nasdaq
- CHSCL Nasdaq
- Market Cap
- SMTI 252.1M
- CHSCL N/A
- IPO Year
- SMTI N/A
- CHSCL N/A
- Fundamental
- Price
- SMTI $29.65
- CHSCL $25.47
- Analyst Decision
- SMTI Strong Buy
- CHSCL
- Analyst Count
- SMTI 2
- CHSCL 0
- Target Price
- SMTI $49.50
- CHSCL N/A
- AVG Volume (30 Days)
- SMTI 45.1K
- CHSCL N/A
- Earning Date
- SMTI 08-11-2025
- CHSCL N/A
- Dividend Yield
- SMTI N/A
- CHSCL N/A
- EPS Growth
- SMTI N/A
- CHSCL N/A
- EPS
- SMTI N/A
- CHSCL N/A
- Revenue
- SMTI $91,569,883.00
- CHSCL N/A
- Revenue This Year
- SMTI $23.53
- CHSCL N/A
- Revenue Next Year
- SMTI $5.93
- CHSCL N/A
- P/E Ratio
- SMTI N/A
- CHSCL N/A
- Revenue Growth
- SMTI 34.65
- CHSCL N/A
- 52 Week Low
- SMTI $25.86
- CHSCL N/A
- 52 Week High
- SMTI $39.08
- CHSCL N/A
- Technical
- Relative Strength Index (RSI)
- SMTI 54.56
- CHSCL 45.11
- Support Level
- SMTI $28.00
- CHSCL $25.15
- Resistance Level
- SMTI $30.59
- CHSCL $25.57
- Average True Range (ATR)
- SMTI 1.22
- CHSCL 0.20
- MACD
- SMTI 0.27
- CHSCL -0.01
- Stochastic Oscillator
- SMTI 74.93
- CHSCL 48.48
About SMTI Sanara MedTech Inc.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.
About CHSCL CHS Inc Class B Cumulative Redeemable Preferred Stock Series 4
CHS Inc is an integrated agricultural enterprise, that provides grain, food, and energy resources to businesses and consumers. Its Energy segment produces and provides wholesale distribution of petroleum products and transportation of those products. Its Ag segment, which is the key revenue driver, purchases and processes or resells grains and oilseeds; serves as a wholesaler and retailer of crop inputs; produces and markets ethanol. Its Nitrogen Production segment consists of equity method investment in CF Nitrogen, which entitles the purchase of up to a specified quantity of granular urea and UAN annually from CF Nitrogen. Geographically, the company derives maximum revenue from North America and the rest from South America, Asia Pacific, Europe, Middle East, and Africa (EMEA).